Protalix Biotherapeutics Inc (PLX)
Investing Cash Flow
-$3.64M
Quarterly · Period ending: · USD
PLX Investing Cash Flow
Latest reported-$3.64Mperiod ending
Latest reported-$3.64Mperiod ending
PLX Quarterly Cash from Investing ($70.00K → -$3.64M)
Quarterly investing cash flow
High-resolution chart · PNG
PLX investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -3,635,000 | |
| 4,223,000 | |
| -1,112,000 | |
| -504,000 | |
| -438,000 | |
| -312,000 | |
| -15,320,000 | |
| 20,327,000 | |
| -180,000 | |
| -606,000 | |
| -342,000 | |
| -20,879,000 | |
| -222,000 | |
| 4,732,000 | |
| 4,953,000 | |
| 5,912,000 | |
| 357,000 | |
| -16,257,000 | |
| 37,436,000 | |
| 4,629,000 | |
| 7,540,000 | |
| -30,684,000 | |
| 7,592,000 | |
| 7,803,000 | |
| -268,000 | |
| -35,079,000 | |
| 29,000 | |
| -446,000 | |
| -95,000 | |
| -371,000 | |
| 84,000 | |
| -228,000 | |
| -119,000 | |
| -328,000 | |
| -34,000 | |
| -116,000 | |
| -686,000 | |
| -283,000 | |
| -242,000 | |
| -66,000 | |
| -366,000 | |
| -293,000 | |
| 39,903,000 | |
| -169,000 | |
| -248,000 | |
| -99,000 | |
| -169,000 | |
| -267,000 | |
| -195,000 | |
| -370,000 | |
| -271,000 | |
| -419,000 | |
| -723,000 | |
| -689,000 | |
| -376,000 | |
| -819,000 | |
| -239,000 | |
| -852,000 | |
| -747,000 | |
| -1,028,000 | |
| -1,443,000 | |
| -2,650,000 | |
| -1,075,000 | |
| -1,384,000 | |
| -2,530,000 | |
| -3,003,000 | |
| -541,000 | |
| -1,441,000 | |
| -2,928,000 | |
| -1,264,000 | |
| -760,000 | |
| -956,000 | |
| -1,129,000 | |
| -856,000 | |
| -1,301,000 | |
| -293,000 | |
| -310,000 | |
| -534,000 | |
| -980,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 552,359 | |
| 0 | |
| -552,359 | |
| 0 | |
| 0 | |
| 60,881 | |
| 10,285 | |
| 9,538 | |
| 9,384 | |
| 9,383 | |
| 1,308,266 | |
| 20,228 |